News 
Market Data 
Discover
Arbel
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$$$TechnoAnalyst Rules$$$
This is awesome $200 prize!! Great way to start the week! 
Board marked! #270 
Terralene Fuels Corporation ($GSPT) - More Than Just A Fuel
Most countries have now ratified the Kyoto Accord and have introduced mandatory legislation that establishes GhG emissions reduction guidelines and initiatives for the use of transportation biofuels that can be a viable alternative to the increased dependence on fossil fuels. The feasibility of enacting programs to achieve these initiatives can be prohibitive mainly due to the high cost of enacting the legislation in all facets of the economy especially in the wake of the international financial crisis.
TERRALENE® Family of Fuels are a unique and significant fuel formulation that can meet or exceed the Kyoto emission limitations and standards while at the same time TERRALENE®’s overall production program not only addresses environmental and energy issues but also addresses the economic well-being of a “TERRALENE® Project Country”.
The use of the TERRALENE® Family of Fuels can expand the time frame of the depletion of the existing oil fields for use by 20% or more because a majority of the components in the fuel blends comes from non fossil fuel sources.
Producing TERRALENE® will help to offset the high cost of importing transportation fuels.
The production of the components for TERRALENE® in a Project County will ensure feasibility, sustainability and security for the local market.
For the production of the components forTERRALENE®, Joint Venture Partners in the “Project Country” intend to implement a large scale Technology Program to produce the non food chain agriculture components for the TERRALENE® Family of Fuels using low-tech labour methods.
GOALS of the Program are comprised of these main areas:
Economic Development and Employment for both Urban and Rural Communities
Production of large amounts of potable water suitable for drinking, sewage disposal and irrigation
Production of Value Added Products for the local consumer and for export
Generation of environmentally friendly electricity for local and countywide consumption
Reforestation in areas that meet this requirement
Reduction of GHG and other harmful environmental emissions
Creation of Carbon Emissions Credits as an additional source of revenue
This mass scale employment program will help eliminate poverty in Project Countries by creating valuable commodities including; ethanol, grain, pulp & paper, feedstock for electricity production, and fabricated panel boards that can be used as alternative green building materials.
Effectively this program will employ and feed the people while providing building material for housing in the Project Countries and other developing countries of the world.
The process is essentially a labour intensive program that will provide employment opportunities to the local population. The objective is to organize the local farmers in the Project Country into an Agricultural Energy Cooperative (AEC), which will empower the people to become energy self-sufficient and provide large economic benefits to the local economy.
The Program will be based on using all the available marginal agriculture lands in the Project Country for growing the agricultural components for the TERRALENE® Family of Environmental Fuels without taking land away from the growing of important food chain agricultural crops.
A Project Countries’ agricultural sector may also find benefits by finding increasing demand for specialized crop production to support a developing fermentation industry. There is also the distinct possibility of franchising production facilities tailored to local needs, which could provide jobs, security, and debt relief without affecting the food chain production for that country.
Various non food chain agricultural crops will be utilized that are suitable for the growing environment in the Project Country especially in marginal soil conditions that are not suitable for growing food chain agricultural crops.
In many areas of the world, contamination of ground water sources and increased global warming has created severe potable water shortages. Production of large amounts of potable water suitable for drinking, sewage disposal and irrigation will also be produced as a by-product of the distillation of the components from the cellulose plant based processing facility that will be set up in the Project Country to produce some of the components for the TERRALENE® Family of Fuels. The inclusion of a desalination plant to process potable water to help ease the water shortage in certain areas of the Project Country could also be feasible.
Some value added products could be produced such as wood fibre for housing panel boards and other sustainable by-products in the production of some of the components from cellulose based plant material for TERRALENE®. This will create additional employment in more sustainable jobs especially in rural areas of the Project Country with additional revenue streams to the operations thereby reviving the agriculture sector and saving the forest industry.
The harvested stocks and leaves will be used for the production of the agricultural components for the TERRALENE® Family of Environmental Fuels and then using the Biomass from the harvested stocks and branches and leaves for building components or for use in a small scale Carbon Neutral Cogeneration Plant for use in the oil extraction and ethanol processing facility.
On a larger scale could be a Carbon Neutral Electric Power Co-generation Plant (Combined Heat and Power) for the TERRALENE® component production processes but also the extra electrical generation could be sold to the local power grid to significantly decrease the use of imported fossil fuels for electric power generation for the Project Country. The larger scale plant would use other biomass products such as;
Other agricultural residues from straw, pruning from vineyards and fruit trees etc.
Livestock waste from wet and dry manure.
Industrial residues from industrial waste wood, sawdust from sawmills and fibrous vegetable waste from paper industries.
Dry lingo-cellulosic from residues from parks and gardens (e.g. pruning, grass)
Contaminated waste from demolition wood, organic fraction of municipal solid waste, biodegradable landfilled waste, landfill gas and sewage sludge.
Using cellulose based plant biomass and other waste biomass for electrical generation in a CHP co-generation plant will help to offset the use of fossil fuels for electric power generation thus reducing GhG emissions in the Project Country and thus having less of a reliance on foreign oil imports and in the same time creating Carbon Trading Credits.
Some of the components for TERRALENE® can be produced using closed structures called Photobioreactors in Small Greenhouses. The land area is greatly reduced because these small greenhouses can be set up to work as individual privately owned processes in a co-operative setting generating income for the private homeowner or can be used on a larger scale where huge volumes of oil can be produced in limited spaces.
Also in this process, Carbon Dioxide (CO2) is captured from the biomass CHP co-generation processing plant and pumped into the closed greenhouses to help generate the CO2 requirement for enhanced growth. Other areas of CO2 by-product production in the country that are mainly from nearby coal fired and diesel electrical generation plants can also be captured for use in the greenhouses thereby generating additional CER’s (Certified Emission Reduction Credits).
TERRALENE® is proven to reduce GhG emissions significantly. The use of TERRALENE® in the transportation market will allow the Project Country to significantly reduce GhG’s and other harmful emissions in major metropolitan areas. This will allow the creation of emission reduction credits called Mobile Emission Reduction Credits (MERC) generated within the transportation sector that can be traded internationally creating additional revenue to offset the high cost of importing transportation fuels and for other infrastructure costs.
These Carbon Trading Credits (CER’s and MERC’s) are very valuable now, will continue to rise in the international market place, and are highly sought after by the international community. As more and more stringent GhG emission standards are mandated throughout the world, the value of these fully tradable carbon credits will also continue to rise in value.
These carbon trading credits not only have cash value but can be used as “offsets” to areas in the country that are producing GhG emissions such as in the coal fired electrical generation plants and in heavy industrial areas. These carbon trading credit offsets will be invaluable as the Project Country transitions to more environmentally friendly and economically feasible sources of alternative fuels.
GSPT – HUGE opportunity hard to pass up.
Investors definitely want to be holders over this “SUPER BOWL” weekend and no doubt GSPT is set now at the best buying level opportunity for HUGE gains. With our European base getting targeted big time over the weekend, next week we are looking at record breaking levels, just as we have seen EKNL developed over the weeks since our initial alert.
GSPT is consolidating nicely after our initial 1,200% gains since our $0.0016 alert, and shares are being shifted in much stronger hands – we are definitely taking advantage of these super cheap levels.
We have also seen GSPT soar in 2010 on our initial alert to hit $0.13. With a $0.10 price target and super low float of 57 million shares, investors stand to gain more than 500%+.
The GSPT story is HUGE. With gas and oil prices continue to escalate and getting out of control, people are looking towards alternative and cheaper fuel source. GSPT has the solution with their patented technology Terralene - no doubt we will be seeing more government mandates to push alternative energy and GSPT is right on track to become a MAJOR player.
Breathe Clean with TERRALENE®
There is an increasing demand for alternative renewable fuels to help to alleviate the effect of harmful mobile vehicle emissions in the environment. This demand for alternative renewable fuels will continue to grow as existing fossil fuel feedstocks increase in price or become difficult to secure and as countries attack the real threat of global warming. Just as there are fuels for transportation, heating, cooling and operating installations, so is there a demand for alternative fuels for these various applications.
The TERRALENE® Family of Fuels are designed to meet a broad range of these fuel needs. TERRALENE® is somewhat based upon fossil fuels and non food chain agricultural components. They are designed as a replacement clean & green Alternative Renewable Fuel that is able to satisfy currently existing engine designs at the same time addressing environmental concerns. The TERRALENE® Family of Fuels are also designed to enhance the economic well being of the consumer while reducing the dependence on fossil fuel feedstocks.
Mobile vehicle emissions concerns that are believed to present the greatest health risk and global warming include carbon dioxide (CO2), carbon monoxide (CO), ozone, sulphur dioxide (SOx), nitrogen dioxide (NOx), particulate matter (PM), acetaldehyde, acrolein, benzene, 1,3-butadiene, formaldehyde, lead and diesel exhaust.
In very recent history, we have seen the development of methanol and ethanol containing fuels such as E10 and E85. Both were quickly determined to be less than acceptable solutions to the above-described problems. After extensive in-house testing and data analysis, including third party validation, TERRALENE® fuels have been developed to address these concerns that other present day alternative fuels fail to address.
TERRALENE® fuels significantly reduce harmful vehicle emissions but they are also a stand-alone fuel that meet the criteria of low production cost, are not part of the food chain process and are able to satisfy the emissions reduction requirements that are mandated by the Kyoto Accord. TERRALENE® fuels are also able to meet the Alternative Renewable Fuel Specifications that are becoming standardized throughout the world.
GREEN technology and alternative fuel is no longer in the distant future, it is here and it’s now – GSPT has a foot hold that will definitely make a splash in the market place.
GSPT – HUGE opportunity hard to pass up.
Investors definitely want to be holders over this “SUPER BOWL” weekend and no doubt GSPT is set now at the best buying level opportunity for HUGE gains. With our European base getting targeted big time over the weekend, next week we are looking at record breaking levels, just as we have seen EKNL developed over the weeks since our initial alert.
GSPT is consolidating nicely after our initial 1,200% gains since our $0.0016 alert, and shares are being shifted in much stronger hands – we are definitely taking advantage of these super cheap levels.
We have also seen GSPT soar in 2010 on our initial alert to hit $0.13. With a $0.10 price target and super low float of 57 million shares, investors stand to gain more than 500%+.
The GSPT story is HUGE. With gas and oil prices continue to escalate and getting out of control, people are looking towards alternative and cheaper fuel source. GSPT has the solution with their patented technology Terralene - no doubt we will be seeing more government mandates to push alternative energy and GSPT is right on track to become a MAJOR player.
Breathe Clean with TERRALENE®
There is an increasing demand for alternative renewable fuels to help to alleviate the effect of harmful mobile vehicle emissions in the environment. This demand for alternative renewable fuels will continue to grow as existing fossil fuel feedstocks increase in price or become difficult to secure and as countries attack the real threat of global warming. Just as there are fuels for transportation, heating, cooling and operating installations, so is there a demand for alternative fuels for these various applications.
The TERRALENE® Family of Fuels are designed to meet a broad range of these fuel needs. TERRALENE® is somewhat based upon fossil fuels and non food chain agricultural components. They are designed as a replacement clean & green Alternative Renewable Fuel that is able to satisfy currently existing engine designs at the same time addressing environmental concerns. The TERRALENE® Family of Fuels are also designed to enhance the economic well being of the consumer while reducing the dependence on fossil fuel feedstocks.
Mobile vehicle emissions concerns that are believed to present the greatest health risk and global warming include carbon dioxide (CO2), carbon monoxide (CO), ozone, sulphur dioxide (SOx), nitrogen dioxide (NOx), particulate matter (PM), acetaldehyde, acrolein, benzene, 1,3-butadiene, formaldehyde, lead and diesel exhaust.
In very recent history, we have seen the development of methanol and ethanol containing fuels such as E10 and E85. Both were quickly determined to be less than acceptable solutions to the above-described problems. After extensive in-house testing and data analysis, including third party validation, TERRALENE® fuels have been developed to address these concerns that other present day alternative fuels fail to address.
TERRALENE® fuels significantly reduce harmful vehicle emissions but they are also a stand-alone fuel that meet the criteria of low production cost, are not part of the food chain process and are able to satisfy the emissions reduction requirements that are mandated by the Kyoto Accord. TERRALENE® fuels are also able to meet the Alternative Renewable Fuel Specifications that are becoming standardized throughout the world.
GREEN technology and alternative fuel is no longer in the distant future, it is here and it’s now – GSPT has a foot hold that will definitely make a splash in the market place.
$EKNL – Goals ‘Insiders’ definitely have in mind
If investors were not convinced by EKO International (EKNL) looking to add HUGE value for its shareholders when they announced their plan of a share buyback program in October,
EKNL – Announces share buy-back, reduces authorized! October 15th, 2012
the company definitely confirmed it last week with the announcement of the “active” share float reduction by 20% and for sure looking to reduce the active float even more.
Definition of ‘Share Buyback’
The repurchase of outstanding shares (repurchase) by a company in order to reduce the number of shares on the market. Companies will buy back shares primarily to increase the value of shares still available (reducing supply)
EKNL – Active float just got reduced 20% by 1.1M shares! January 10th, 2013
The Company also wishes to announce that, according to its records, the number of shares held by CEDE currently stands at 4,431,423 which is a reduction from the share number of 5,579,423 previously announced on October 31, 2012. http://finance.yahoo.com/news/eko-international-corp-appointment-director-144000608.html
This is insane, the only reason to buy back shares is of course to move prices up, but the underlying reason would be to get uplisted to the NASDAQ or NYSE board!
This was confirmed when the company announcement selecting MaloneBailey LLP, Certified Public Accounting Firm for appointment as auditors of the Company.
“The Company is in the process of retaining an in-house accountant and qualified auditors for the purpose of upgrading the Company’s tier on the OTC Markets as the next step toward providing investors with the “highest financial standards and superior information availability” – OTC Markets”
So reducing float, share buyback, auditor selection sure does seem to be telling an interesting story. This is definitely a unique play rarely heard of with an OTC listed company that looks to be preparing for an uplisting to the broader exchange like NASDAQ & NYSE!
Now, it gets even better, EKNL with JV partner Neurovasc has been building a huge network of partnerships, relations, and referrals.
The key relationship with WalMart which they currently have their NC-Stat DPN testing devices for Diabetic Neuropathy are in over 100 of their Stores! Not to mention, key partnerships with iMDhealth.ca network giving EKNL access to thousands of physician, diabetes education centers and health care providers for diabetics across Canada, and first of many Clinics, the Mayer Institute including recent announcement of launching clinics in the USA to treat patients with their FDA approved FREMS technology
Now, here’s the kicker, EKNL recently mentioned they are to attend the Walmart Canada Professional Services Conferences of 2013 in Vancouver, BC (April 4-7) and in Toronto, ON (April 25-28).
Looks like, EKNL is building up something massive towards these Key conferences in April, and definitely looks like they are getting everything in order.
Members definitely do not want to miss out on any opportunity here to scoop unbelievable valued shares. We are keeping our $2 price target in check and with what EKNL has been building over the past few months, we will definitely be there with them as we approach these Key conferences in April.
EKO International Corp.
$EKNL – Goals ‘Insiders’ definitely have in mind
If investors were not convinced by EKO International (EKNL) looking to add HUGE value for its shareholders when they announced their plan of a share buyback program in October,
EKNL – Announces share buy-back, reduces authorized! October 15th, 2012
the company definitely confirmed it last week with the announcement of the “active” share float reduction by 20% and for sure looking to reduce the active float even more.
Definition of ‘Share Buyback’
The repurchase of outstanding shares (repurchase) by a company in order to reduce the number of shares on the market. Companies will buy back shares primarily to increase the value of shares still available (reducing supply)
EKNL – Active float just got reduced 20% by 1.1M shares! January 10th, 2013
The Company also wishes to announce that, according to its records, the number of shares held by CEDE currently stands at 4,431,423 which is a reduction from the share number of 5,579,423 previously announced on October 31, 2012. http://finance.yahoo.com/news/eko-international-corp-appointment-director-144000608.html
This is insane, the only reason to buy back shares is of course to move prices up, but the underlying reason would be to get uplisted to the NASDAQ or NYSE board!
This was confirmed when the company announcement selecting MaloneBailey LLP, Certified Public Accounting Firm for appointment as auditors of the Company.
“The Company is in the process of retaining an in-house accountant and qualified auditors for the purpose of upgrading the Company’s tier on the OTC Markets as the next step toward providing investors with the “highest financial standards and superior information availability” – OTC Markets”
So reducing float, share buyback, auditor selection sure does seem to be telling an interesting story. This is definitely a unique play rarely heard of with an OTC listed company that looks to be preparing for an uplisting to the broader exchange like NASDAQ & NYSE!
Now, it gets even better, EKNL with JV partner Neurovasc has been building a huge network of partnerships, relations, and referrals.
The key relationship with WalMart which they currently have their NC-Stat DPN testing devices for Diabetic Neuropathy are in over 100 of their Stores! Not to mention, key partnerships with iMDhealth.ca network giving EKNL access to thousands of physician, diabetes education centers and health care providers for diabetics across Canada, and first of many Clinics, the Mayer Institute including recent announcement of launching clinics in the USA to treat patients with their FDA approved FREMS technology
Now, here’s the kicker, EKNL recently mentioned they are to attend the Walmart Canada Professional Services Conferences of 2013 in Vancouver, BC (April 4-7) and in Toronto, ON (April 25-28).
Looks like, EKNL is building up something massive towards these Key conferences in April, and definitely looks like they are getting everything in order.
Members definitely do not want to miss out on any opportunity here to scoop unbelievable valued shares. We are keeping our $2 price target in check and with what EKNL has been building over the past few months, we will definitely be there with them as we approach these Key conferences in April.
EKO International Corp.
$EKNL, DROP – Making a move and set for Major Week Ahead.
EKNL and DROP closed the Friday session with solid green performances and looks like they have their groove back for a HUGE week ahead.
Holiday’s are behind us now, and Wall Street is in full trading mode. We are expecting monster key news this week that will really get the action going.
EKNL continues to hold solid to over 1,000% gains since our initial alert at $0.04 for close to 4 months! This definitely tells investors, shares are in super strong hands, and definitely not willing to sell at these super cheap levels.
In fact, with our price target of $2 per share will not only give this weeks buyers 500%+ gains, we anticipate with the news lineup expected, this can move very quick. Share inventory is super thin, getting in early will maximize potential gains here!
EKNL‘s technical chart is definitely set up for a major breakout this week. Closing at $0.425 up 11.84% marks the bullish reversal and looking to move towards record prices once again.
Investors definitely want to be on side when breakout action is triggered, with a super low float of 5.5 million shares and all held by long strong hands, there is very little shares available at these cheap levels.
EKO International Corp.
ABOUT EKO INTERNATIONAL
EKO International Corp. is a holding company focused on growth through acquisition. Each acquisition must have substantial growth potential and is expected to add assets and/or cash-flow to the consolidated financial statements of the Company. The Company is willing to examine a variety of proposed target businesses and if interested, will negotiate terms and conditions of purchase favorable to itself.
http://www.poweredbyfuse.com/wp-content/themes/poweredbyfuse/images/logo.png
About Fuse Science, Inc.
Fuse Science, Inc. (DROP), is an innovative consumer products holding company based in Miami Lakes, Florida. Fuse Science holds the rights to new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals. The company maintains the rights to sublingual and transdermal delivery systems for bioactive agents that can now, for the first time, effectively encapsulate and charge many varying molecules in order to produce complete product formulations which can bypass the gastrointestinal tract and enter the blood stream directly – all in a concentrated “DROP” form that is simply applied under the tongue. The Fuse Science technology is designed to accelerate conveyance of medicines or nutrients relative to traditional pills and liquids and can enhance how consumers receive these products. Information about Fuse Science is available online at www.fusescience.com and www.poweredbyfuse.com or by calling 305-503-FUSE (3873).
$EKNL, DROP – Making a move and set for Major Week Ahead.
EKNL and DROP closed the Friday session with solid green performances and looks like they have their groove back for a HUGE week ahead.
Holiday’s are behind us now, and Wall Street is in full trading mode. We are expecting monster key news this week that will really get the action going.
EKNL continues to hold solid to over 1,000% gains since our initial alert at $0.04 for close to 4 months! This definitely tells investors, shares are in super strong hands, and definitely not willing to sell at these super cheap levels.
In fact, with our price target of $2 per share will not only give this weeks buyers 500%+ gains, we anticipate with the news lineup expected, this can move very quick. Share inventory is super thin, getting in early will maximize potential gains here!
EKNL‘s technical chart is definitely set up for a major breakout this week. Closing at $0.425 up 11.84% marks the bullish reversal and looking to move towards record prices once again.
Investors definitely want to be on side when breakout action is triggered, with a super low float of 5.5 million shares and all held by long strong hands, there is very little shares available at these cheap levels.
EKO International Corp.
ABOUT EKO INTERNATIONAL
EKO International Corp. is a holding company focused on growth through acquisition. Each acquisition must have substantial growth potential and is expected to add assets and/or cash-flow to the consolidated financial statements of the Company. The Company is willing to examine a variety of proposed target businesses and if interested, will negotiate terms and conditions of purchase favorable to itself.
http://www.poweredbyfuse.com/wp-content/themes/poweredbyfuse/images/logo.png
About Fuse Science, Inc.
Fuse Science, Inc. (DROP), is an innovative consumer products holding company based in Miami Lakes, Florida. Fuse Science holds the rights to new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals. The company maintains the rights to sublingual and transdermal delivery systems for bioactive agents that can now, for the first time, effectively encapsulate and charge many varying molecules in order to produce complete product formulations which can bypass the gastrointestinal tract and enter the blood stream directly – all in a concentrated “DROP” form that is simply applied under the tongue. The Fuse Science technology is designed to accelerate conveyance of medicines or nutrients relative to traditional pills and liquids and can enhance how consumers receive these products. Information about Fuse Science is available online at www.fusescience.com and www.poweredbyfuse.com or by calling 305-503-FUSE (3873).
$EKNL, DROP – Diabetes Care and Treatment will be Top priority in 2013
Both core plays continue to hold solid to Monster gains and early indication in the first trading days of the New Year definitely is showing major action in the works and ready for a major breakout at any time.
We anticipate huge news in the coming days that will definitely stir major action and members definitely want to be in the game when it does.
Diabetes care specifically will be front and center for 2013 and the need for improvement in their healthcare across the country top priority.
“This clearly shows that the government needs to make diabetes a national priority and to insist that 2013 is the year when people with diabetes really start to notice their healthcare improving,” http://www.moneyexpert.com/financial-news/none/800581469/diabetescarenotimproving,revealscharitysurvey/article.aspx
With the upcoming OneMedForum SF 2013 conference in San Fransisco on Jan 7-9th http://www.onemedplace.com/forum, diabetes screening and treatment will definitely be a hot topic starting withhttp://www.neurometrix.com/Collateral/Images/Common/NC-stat-DPN-Check-device-with-numbers-v7-revised.jpg Neurometrix (NASDAQ:NURO)’s NC-Stat DPN check device which will be presented at the conference.
NeuroMetrix, Inc. (NAS: NURO) , www.neurometrix.com, a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, today announced that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, is scheduled to speak at the 6th Annual OneMedForum at the Sir Frances Drake Hotel, San Francisco, CA on January 7-9, 2013. Dr. Gozani intends to provide an update on the Company’s business activities and on its diabetes products including NC-stat® DPNCheck™, a diagnostic test for systemic neuropathies such as diabetic peripheral neuropathy (DPN), and the SENSUS™ pain management device for relief of chronic intractable pain. http://www.onemedplace.com/forum/6th-annual-onemedforum-presenting-companies
This will no doubt push the awareness of these NC-Stat DPN testing devices to an whole new level and “in the face” of USA Medical Professionals across the country – and no doubt increase awareness of EKNL/NCI diabetes treatment with their FDA approved FREMS technology.
With key monster news ready to be unleashed and key dates to keep close eye on, EKNL is definitely at super bargain levels with 500%+ gain potential towards our $2.00 price target!
Good Morning Xtreme Players $EKNL Holding and going long here!
$EKNL Trying to break the 50DMA. We break this level we will be primed to run towards $$ land..
$EKNL Primed and ready for our next move up!
$EKNL and DROP started the week in xtreme fashion both closing solid green – definitely keep a close watch on these plays for breakout action this week it definitely showing signs this is very close at hand.
Updated Research report will be issued this week on both DROP and EKNL
DROP jumped 10.27% today to close at its highest levels since the summer months and we expect an update on their new product that was launched online this month:
“new Drop Technology products, PowerFuse™ and ElectroFuse™ will be available online commencing December 1, 2012, at www.poweredbyfuse.com
With Tiger Woods and Arian Foster as spokemen, no doubt will have a solid impact on sales. We have seen how trigger breakout news can move stocks and last year at this time DROP soared to $1.25 when “Tiger News” hit the wires. This gave our members a potential 83,000% gains and hitting our price target dead on. We are once again looking at DROP’s current potential for solid gains – keep an eye on our research report coming this week.
EKNL continues to show brute force day after day closing a solid green session at $0.47. EKNL is definitely due for some major news to start hitting the wires to follow up from their last update:
EKO International Corp – NeuroVasc Clinical Inc. marketing updatePR Newswire(Thu Nov 15)
EKNL is definitely hinting to something major is in the works here specifically from their 13th annual medical conference attended in October
We already got confirmation that the company met with key groups to finalize several deals and we expect these deals to be announced very soon.
“In addition to the hundreds of attendees who will be introduced to NCI products, NCI will be providing demonstrations to a number of parties who have expressed serious interest in FREMS and are attending to finalize purchasing arrangements” http://finance.yahoo.com/news/eko-international-corp-nerovasc-clinical-150600594.html
Definitely we can see additional major relationships following already announced agreement with iMD Network giving EKNL direct access to thousands of doctors for referrals of Diabetic patients with Neuropathy and the need of their FREMS equipment. Additionally, their NC Stat DPN testing devices are already in over 100 Walmart stores.
No doubt, if the NC Stat device is already in one store chain, the possibility of more Walmart stores and other chain to follow is pretty good. Not to mention, the company alluded to announcing which Walmart stores already deploy the NC Stat testing devices.
The Company will shortly be providing information on locations, including the WalMart pharmacies, where testing facilities are available for patients suffering from DPN.
EKNL also announced launching of clinics for their FREMS Technology including the Mayer Institute and their first of many clinics to be opened in the USA – this is a HUGE step forward for EKNL. Not only do they have a big presence in Canada, and even teaming up with 100 Walmart stores with the NC Stat Testing device, they just announced tapping into the US market which is absolutely HUGE.
EKO INTERNATIONAL INC. (the “Company”) – (EKNL) is pleased to announce that marketing efforts initiated prior to the Canadian Federation of Podiatric Medicine Conference held in London, Ontario on October 26th and 27th, 2012, have resulted in the preparation of clinical facilities in Chicago Illinois and Sault Ste. Marie, Ontario, Canada by health professionals to administer tests and to provide treatments for diabetic patients suffering from peripheral neuropathy.
No doubt, we can see a series of updates announcing more and more clinics being launched adding the base to increase their $$ bottom lines substantially.
EKNL already provided us with an update that the company is planning for uplisting and with MaloneBailey LLP, Certified Public Accounting Firm as auditors of the Company and the share buyback program already in place we can definitely see updates on their progress – Nasdaq bound listing may very well be close at hand.
And, No doubt with the share buyback program in effect, we are definitely keeping a very close eye on the active float of 5.5 million shares and expected reduction in this number.
There is one thing for sure, we expect significant news from EKNL and “No doubt” will see a flurry of update very soon. With $2 near term price target in sights, investors stand to more than triple gains at current trading levels which closed today at $0.47 and holding solid to over 1,000% gains for close to 3 months since our initial alert at $0.04. Shares are in super strong hands definitely holding well into multi-dollar levels.
$EKNL and DROP started the week in xtreme fashion both closing solid green – definitely keep a close watch on these plays for breakout action this week it definitely showing signs this is very close at hand.
Updated Research report will be issued this week on both DROP and EKNL
DROP jumped 10.27% today to close at its highest levels since the summer months and we expect an update on their new product that was launched online this month:
“new Drop Technology products, PowerFuse™ and ElectroFuse™ will be available online commencing December 1, 2012, at www.poweredbyfuse.com
With Tiger Woods and Arian Foster as spokemen, no doubt will have a solid impact on sales. We have seen how trigger breakout news can move stocks and last year at this time DROP soared to $1.25 when “Tiger News” hit the wires. This gave our members a potential 83,000% gains and hitting our price target dead on. We are once again looking at DROP’s current potential for solid gains – keep an eye on our research report coming this week.
EKNL continues to show brute force day after day closing a solid green session at $0.47. EKNL is definitely due for some major news to start hitting the wires to follow up from their last update:
EKO International Corp – NeuroVasc Clinical Inc. marketing updatePR Newswire(Thu Nov 15)
EKNL is definitely hinting to something major is in the works here specifically from their 13th annual medical conference attended in October
We already got confirmation that the company met with key groups to finalize several deals and we expect these deals to be announced very soon.
“In addition to the hundreds of attendees who will be introduced to NCI products, NCI will be providing demonstrations to a number of parties who have expressed serious interest in FREMS and are attending to finalize purchasing arrangements” http://finance.yahoo.com/news/eko-international-corp-nerovasc-clinical-150600594.html
Definitely we can see additional major relationships following already announced agreement with iMD Network giving EKNL direct access to thousands of doctors for referrals of Diabetic patients with Neuropathy and the need of their FREMS equipment. Additionally, their NC Stat DPN testing devices are already in over 100 Walmart stores.
No doubt, if the NC Stat device is already in one store chain, the possibility of more Walmart stores and other chain to follow is pretty good. Not to mention, the company alluded to announcing which Walmart stores already deploy the NC Stat testing devices.
The Company will shortly be providing information on locations, including the WalMart pharmacies, where testing facilities are available for patients suffering from DPN.
EKNL also announced launching of clinics for their FREMS Technology including the Mayer Institute and their first of many clinics to be opened in the USA – this is a HUGE step forward for EKNL. Not only do they have a big presence in Canada, and even teaming up with 100 Walmart stores with the NC Stat Testing device, they just announced tapping into the US market which is absolutely HUGE.
EKO INTERNATIONAL INC. (the “Company”) – (EKNL) is pleased to announce that marketing efforts initiated prior to the Canadian Federation of Podiatric Medicine Conference held in London, Ontario on October 26th and 27th, 2012, have resulted in the preparation of clinical facilities in Chicago Illinois and Sault Ste. Marie, Ontario, Canada by health professionals to administer tests and to provide treatments for diabetic patients suffering from peripheral neuropathy.
No doubt, we can see a series of updates announcing more and more clinics being launched adding the base to increase their $$ bottom lines substantially.
EKNL already provided us with an update that the company is planning for uplisting and with MaloneBailey LLP, Certified Public Accounting Firm as auditors of the Company and the share buyback program already in place we can definitely see updates on their progress – Nasdaq bound listing may very well be close at hand.
And, No doubt with the share buyback program in effect, we are definitely keeping a very close eye on the active float of 5.5 million shares and expected reduction in this number.
There is one thing for sure, we expect significant news from EKNL and “No doubt” will see a flurry of update very soon. With $2 near term price target in sights, investors stand to more than triple gains at current trading levels which closed today at $0.47 and holding solid to over 1,000% gains for close to 3 months since our initial alert at $0.04. Shares are in super strong hands definitely holding well into multi-dollar levels.
$EKNL Holding strong and expecting "MOASS" real soon
$EKNL is on the edge of a HUGE breakout that can see prices soaring to multi-dollar land with KEY updates the company is expected to release from their marketing efforts from the recent Medical Conference in London – December is typically the best market gainer month if looking at the average returns over 40 years.
Interesting enough, the chart below shows the market indices performance by month with December booking the highest return month – these stocks made up primarily of large cap stocks but have a direct correlation impact on the penny stock market. With solid long term plays like EKNL, investors will definitely feel the December effect just as DROP did in 2011 reaching our $1.25 target bang on! With key breakout news ready to be unleashed, and super thin stock inventory, EKNL is primed for the biggest month on record!
The key to MEGA gains for EKNL in December is breakout trigger news and EKNL already hinted several times what the possible news can be – and we definitely expect it at any time!
We already got confirmation that the company met with key groups to finalize several deals and we expect these deals to be announced very soon.
“In addition to the hundreds of attendees who will be introduced to NCI products, NCI will be providing demonstrations to a number of parties who have expressed serious interest in FREMS and are attending to finalize purchasing arrangements” http://finance.yahoo.com/news/eko-international-corp-nerovasc-clinical-150600594.html
This is definitely a very strong statement by the company to make, and making it is a solid hint that several Major contracts are practically done and ready to be unleashed. We are on HIGH ALERT for an update on these major contacts.
Definitely we can see additional major relationships following already announced agreement with iMD Network giving EKNL direct access to thousands of doctors for referrals of Diabetic patients with Neuropathy and the need of their FREMS equipment. Additionally, their NC Stat DPN testing devices are already in over 100 Walmart stores.
No doubt, if the NC Stat device is already in one store chain, the possibility of more Walmart stores and other chain to follow is pretty good. Not to mention, the company alluded to announcing which Walmart stores already deploy the NC Stat testing devices.
The Company will shortly be providing information on locations, including the WalMart pharmacies, where testing facilities are available for patients suffering from DPN.
EKNL also announced launching of clinics for their FREMS Technology including the Mayer Institute and their first of many clinics to be opened in the USA – this is a HUGE step forward for EKNL. Not only do they have a big presence in Canada, and even teaming up with 100 Walmart stores with the NC Stat Testing device, they just announced tapping into the US market which is absolutely HUGE.
EKO INTERNATIONAL INC. (the “Company”) – (EKNL) is pleased to announce that marketing efforts initiated prior to the Canadian Federation of Podiatric Medicine Conference held in London, Ontario on October 26th and 27th, 2012, have resulted in the preparation of clinical facilities in Chicago Illinois and Sault Ste. Marie, Ontario, Canada by health professionals to administer tests and to provide treatments for diabetic patients suffering from peripheral neuropathy.
No doubt, we can see a series of updates announcing more and more clinics being launched adding the base to increase their $$ bottom lines substantially.
EKNL already provided us with an update that the company is planning for uplisting and with MaloneBailey LLP, Certified Public Accounting Firm as auditors of the Company and the share buyback program already in place we can definitely see updates on their progress – Nasdaq bound listing may very well be close at hand.
And, No doubt with the share buyback program in effect, we are definitely keeping a very close eye on the active float of 5.5 million shares and expected reduction in this number.
There is one thing for sure, we expect significant news from EKNL and “No doubt” will see a flurry of update very soon. With $2 near term price target in sights, investors stand to more than triple gains at current trading levels which closed today at $0.50 and holding solid to over 1,200% gains for over 2 months since our initial alert at $0.04. Shares are in super strong hands definitely holding well into multi-dollar levels.
Key points that make EKNL an XTREME breakout play:
1) No dilution or insiders selling any time soon and especially at these super low prices.
2) Share buyback in effect. Definitely the reason here is to move prices up to proper valuations and big boards like Nasdaq requirements. We also got confirmation with recent announcement selecting MaloneBailey LLP, Certified Public Accounting Firm as auditors of the Company.
3) Super Low float. With only 5.5 Million active float (shares available at the DTC for trading), EKNL‘s share inventory is drying up super fast, and this is already triggering a MAJOR BULLISH BREAKOUT. We expect this number to significantly reduce as the company begins their buyback program.
$EKNL is on the edge of a HUGE breakout that can see prices soaring to multi-dollar land with KEY updates the company is expected to release from their marketing efforts from the recent Medical Conference in London – December is typically the best market gainer month if looking at the average returns over 40 years.
Interesting enough, the chart below shows the market indices performance by month with December booking the highest return month – these stocks made up primarily of large cap stocks but have a direct correlation impact on the penny stock market. With solid long term plays like EKNL, investors will definitely feel the December effect just as DROP did in 2011 reaching our $1.25 target bang on! With key breakout news ready to be unleashed, and super thin stock inventory, EKNL is primed for the biggest month on record!
The key to MEGA gains for EKNL in December is breakout trigger news and EKNL already hinted several times what the possible news can be – and we definitely expect it at any time!
We already got confirmation that the company met with key groups to finalize several deals and we expect these deals to be announced very soon.
“In addition to the hundreds of attendees who will be introduced to NCI products, NCI will be providing demonstrations to a number of parties who have expressed serious interest in FREMS and are attending to finalize purchasing arrangements” http://finance.yahoo.com/news/eko-international-corp-nerovasc-clinical-150600594.html
This is definitely a very strong statement by the company to make, and making it is a solid hint that several Major contracts are practically done and ready to be unleashed. We are on HIGH ALERT for an update on these major contacts.
Definitely we can see additional major relationships following already announced agreement with iMD Network giving EKNL direct access to thousands of doctors for referrals of Diabetic patients with Neuropathy and the need of their FREMS equipment. Additionally, their NC Stat DPN testing devices are already in over 100 Walmart stores.
No doubt, if the NC Stat device is already in one store chain, the possibility of more Walmart stores and other chain to follow is pretty good. Not to mention, the company alluded to announcing which Walmart stores already deploy the NC Stat testing devices.
The Company will shortly be providing information on locations, including the WalMart pharmacies, where testing facilities are available for patients suffering from DPN.
EKNL also announced launching of clinics for their FREMS Technology including the Mayer Institute and their first of many clinics to be opened in the USA – this is a HUGE step forward for EKNL. Not only do they have a big presence in Canada, and even teaming up with 100 Walmart stores with the NC Stat Testing device, they just announced tapping into the US market which is absolutely HUGE.
EKO INTERNATIONAL INC. (the “Company”) – (EKNL) is pleased to announce that marketing efforts initiated prior to the Canadian Federation of Podiatric Medicine Conference held in London, Ontario on October 26th and 27th, 2012, have resulted in the preparation of clinical facilities in Chicago Illinois and Sault Ste. Marie, Ontario, Canada by health professionals to administer tests and to provide treatments for diabetic patients suffering from peripheral neuropathy.
No doubt, we can see a series of updates announcing more and more clinics being launched adding the base to increase their $$ bottom lines substantially.
EKNL already provided us with an update that the company is planning for uplisting and with MaloneBailey LLP, Certified Public Accounting Firm as auditors of the Company and the share buyback program already in place we can definitely see updates on their progress – Nasdaq bound listing may very well be close at hand.
And, No doubt with the share buyback program in effect, we are definitely keeping a very close eye on the active float of 5.5 million shares and expected reduction in this number.
There is one thing for sure, we expect significant news from EKNL and “No doubt” will see a flurry of update very soon. With $2 near term price target in sights, investors stand to more than triple gains at current trading levels which closed today at $0.50 and holding solid to over 1,200% gains for over 2 months since our initial alert at $0.04. Shares are in super strong hands definitely holding well into multi-dollar levels.
Key points that make EKNL an XTREME breakout play:
1) No dilution or insiders selling any time soon and especially at these super low prices.
2) Share buyback in effect. Definitely the reason here is to move prices up to proper valuations and big boards like Nasdaq requirements. We also got confirmation with recent announcement selecting MaloneBailey LLP, Certified Public Accounting Firm as auditors of the Company.
3) Super Low float. With only 5.5 Million active float (shares available at the DTC for trading), EKNL‘s share inventory is drying up super fast, and this is already triggering a MAJOR BULLISH BREAKOUT. We expect this number to significantly reduce as the company begins their buyback program.
$EKNL – Confirmed Breakout Mode can more than triple this month.
EKNL is now in a monster breakout mode already tacking on 70% since the v-shaped breakout reversal over a week ago. Friday’s session confirmed the bulls are in control breaking though the $0.50 level since 2 weeks ago and up 8.69% on the day.
Last year at this time our 2011 Monster Winner DROP, made an unbelievable run towards our target price of $1.25 making our total tally of 83,000% gains and some members instant millionaire - no doubt we will be looking at a repeat with EKNL this month.
With Major and key news expected from the company very soon, this will definitely be the catalyst to propel prices sky high. The best opportunity to maximize gains are here and now and smart buyers are definitely seeing exactly the HUGE potential for gains.
We already got confirmation that the company met with key groups to finalize several deals and we expect these deals to be announced very soon.
“In addition to the hundreds of attendees who will be introduced to NCI products, NCI will be providing demonstrations to a number of parties who have expressed serious interest in FREMS and are attending to finalize purchasing arrangements” http://finance.yahoo.com/news/eko-international-corp-nerovasc-clinical-150600594.html
This is definitely a very strong statement by the company to make, and making it is a solid hint that several Major contracts are practically done and ready to be unleashed. We are on HIGH ALERT for an update on these major contacts and we are already getting hints that it can be unleashed at any time.
There is one thing for sure, we expect significant news from EKNL and “No doubt” will see a flurry of updates at any time. With $2 near term price target in sights, investors stand to more than triple their portfolio at current trading levels which last traded at $0.50 and holding solid to over 1,000% gains for over 2 months since our initial alert at $0.04. Shares are in super strong hands definitely holding well into multi-dollar levels.
Key points that make EKNL an XTREME breakout play:
1) No dilution or insiders selling any time soon and especially at these super low prices.
2) Share buyback in effect. Definitely the reason here is to move prices up to proper valuations and big boards like Nasdaq requirements. We also got confirmation with recent announcement selecting MaloneBailey LLP, Certified Public Accounting Firm as auditors of the Company.
3) Super Low float. With only 5.5 Million active float (shares available at the DTC for trading), EKNL‘s share inventory is drying up super fast, and this is already triggering a MAJOR BULLISH BREAKOUT. We expect this number to significantly reduce as the company begins their buyback program.
$EKNL – Confirmed Breakout Mode can more than triple this month.
EKNL is now in a monster breakout mode already tacking on 70% since the v-shaped breakout reversal over a week ago. Friday’s session confirmed the bulls are in control breaking though the $0.50 level since 2 weeks ago and up 8.69% on the day.
Last year at this time our 2011 Monster Winner DROP, made an unbelievable run towards our target price of $1.25 making our total tally of 83,000% gains and some members instant millionaire - no doubt we will be looking at a repeat with EKNL this month.
With Major and key news expected from the company very soon, this will definitely be the catalyst to propel prices sky high. The best opportunity to maximize gains are here and now and smart buyers are definitely seeing exactly the HUGE potential for gains.
We already got confirmation that the company met with key groups to finalize several deals and we expect these deals to be announced very soon.
“In addition to the hundreds of attendees who will be introduced to NCI products, NCI will be providing demonstrations to a number of parties who have expressed serious interest in FREMS and are attending to finalize purchasing arrangements” http://finance.yahoo.com/news/eko-international-corp-nerovasc-clinical-150600594.html
This is definitely a very strong statement by the company to make, and making it is a solid hint that several Major contracts are practically done and ready to be unleashed. We are on HIGH ALERT for an update on these major contacts and we are already getting hints that it can be unleashed at any time.
There is one thing for sure, we expect significant news from EKNL and “No doubt” will see a flurry of updates at any time. With $2 near term price target in sights, investors stand to more than triple their portfolio at current trading levels which last traded at $0.50 and holding solid to over 1,000% gains for over 2 months since our initial alert at $0.04. Shares are in super strong hands definitely holding well into multi-dollar levels.
Key points that make EKNL an XTREME breakout play:
1) No dilution or insiders selling any time soon and especially at these super low prices.
2) Share buyback in effect. Definitely the reason here is to move prices up to proper valuations and big boards like Nasdaq requirements. We also got confirmation with recent announcement selecting MaloneBailey LLP, Certified Public Accounting Firm as auditors of the Company.
3) Super Low float. With only 5.5 Million active float (shares available at the DTC for trading), EKNL‘s share inventory is drying up super fast, and this is already triggering a MAJOR BULLISH BREAKOUT. We expect this number to significantly reduce as the company begins their buyback program.
$EKNL Looking Sweet for sure!!
